We are live on ! Find out more
DCM

Dynamic Capital Management Portfolio holdings

AUM $12M
1-Year Est. Return 0.65%
This Fund
S&P 500
This Quarter Est. Return
+3.32%
1 Year Est. Return
-0.65%
3 Year Est. Return
+49.65%
5 Year Est. Return
+20.52%
10 Year Est. Return
AUM
$349M
AUM Growth
-$94.4M
Cap. Flow
-$100M
Cap. Flow %
-28.77%
Top 10 Hldgs %
24.98%
Holding
344
New
109
Increased
63
Reduced
65
Closed
107

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$20.7M
2
STZ icon
Constellation Brands
STZ
+$17.3M
3
BBY icon
Best Buy
BBY
+$13.3M
4
INTU icon
Intuit
INTU
+$12.6M
5
NVS icon
Novartis
NVS
+$11.8M

Sector Composition

Rank Sector Weight
1 Healthcare 18.69%
2 Consumer Discretionary 17.21%
3 Consumer Staples 12.42%
4 Financials 8.84%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$130B
$14.2M 4.07%
+222,501
New +$13M
APD icon
2
Air Products & Chemicals
APD
$65.4B
$11.1M 3.19%
+73,504
New +$10.8M
RHT
3
DELISTED
Red Hat Inc
RHT
$10.4M 2.99%
94,130
-24,317
-21% -$2.49M
MRSH
4
Marsh
MRSH
$94.5B
$9M 2.58%
107,396
+93,399
+667% +$7.4M
PVH icon
5
PVH
PVH
$3.98B
$7.97M 2.29%
63,267
+47,894
+312% +$5.84M
KMX icon
6
CarMax
KMX
$8.55B
$7.97M 2.29%
+105,189
New +$7.01M
SCG
7
DELISTED
Scana
SCG
$6.83M 1.96%
+140,780
New +$8.63M
AGN
8
DELISTED
Allergan plc
AGN
$6.76M 1.94%
+32,991
New +$7.67M
K
9
DELISTED
Kellanova
K
$6.58M 1.89%
112,449
+94,423
+524% +$5.96M
CTAS icon
10
Cintas
CTAS
$87.5B
$6.26M 1.79%
173,448
+55,200
+47% +$1.84M
EL icon
11
Estee Lauder
EL
$30.5B
$6.13M 1.76%
56,830
+50,931
+863% +$5.23M
BBBY
12
DELISTED
Bed Bath & Beyond Inc
BBBY
$5.89M 1.69%
251,047
-23,089
-8% -$647K
GILD icon
13
Gilead Sciences
GILD
$166B
$5.4M 1.55%
66,620
+50,649
+317% +$3.87M
ROST icon
14
Ross Stores
ROST
$80.8B
$4.9M 1.41%
+75,947
New +$4.37M
APC
15
DELISTED
Anadarko Petroleum
APC
$4.57M 1.31%
93,635
+87,045
+1,321% +$3.84M
TSN icon
16
Tyson Foods
TSN
$21.5B
$4.51M 1.29%
+64,000
New +$4.09M
ALV icon
17
Autoliv
ALV
$9.1B
$4.32M 1.24%
+48,466
New +$3.93M
AME icon
18
Ametek
AME
$53.7B
$4.22M 1.21%
+63,833
New +$4.04M
TEVA icon
19
Teva Pharmaceuticals
TEVA
$39.4B
$4.21M 1.21%
+239,126
New +$5.38M
ROP icon
20
Roper Technologies
ROP
$40.3B
$3.95M 1.13%
+16,211
New +$3.81M
DLTR icon
21
Dollar Tree
DLTR
$24.7B
$3.84M 1.1%
44,199
-10,383
-19% -$792K
AJG icon
22
Arthur J. Gallagher & Co
AJG
$69.2B
$3.73M 1.07%
+60,588
New +$3.56M
BF.B icon
23
Brown-Forman Class B
BF.B
$13.6B
$3.67M 1.05%
+105,589
New +$3.43M
INCY icon
24
Incyte
INCY
$25.2B
$3.6M 1.03%
30,867
+26,217
+564% +$3.32M
BMRN icon
25
BioMarin Pharmaceuticals
BMRN
$12B
$3.28M 0.94%
35,281
+21,626
+158% +$1.91M

Similar funds

Dynamic Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Dynamic Capital Management held 344 positions worth $349M, down 21% from $443M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Dynamic Capital Management withdrew a net $100M in Q3 2017, closing 107 positions and reducing 65 holdings. Its most notable exit was Oracle, an estimated $20.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Dynamic Capital Management opened a new position in Bristol-Myers Squibb worth $14.2M.

  • Dynamic Capital Management's largest Q3 2017 buy was Bristol-Myers Squibb: 222,501 shares worth $14.2M.
  • Dynamic Capital Management added most to Marsh in Q3 2017, an estimated $7.4M increase.
  • Dynamic Capital Management's biggest Q3 2017 reduction was Constellation Brands, cutting an estimated $17.3M.
  • Dynamic Capital Management fully exited Oracle in Q3 2017, selling an estimated $20.7M.
  • Dynamic Capital Management's ten largest holdings make up 25% of its $349M portfolio in Q3 2017.
  • Dynamic Capital Management opened 109 new positions and closed 107 in Q3 2017.
  • Dynamic Capital Management's portfolio value fell 21% quarter-over-quarter to $349M.

Based on Dynamic Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.